Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of Evidence-based Reminders on Use of Antibiotics

This study has been completed.
Sponsor:
Collaborators:
Society of Family Medicin La Paz-Bolivia
University of Itapua, Paraguay
University of the Republic, Uruguay
Society of General and Family practice, Misiones- Argentina
Information provided by (Responsible Party):
Gloria Cristina Cordoba, University of Copenhagen
ClinicalTrials.gov Identifier:
NCT02927743
First received: October 5, 2016
Last updated: October 6, 2016
Last verified: October 2016
  Purpose
Inappropriate use of antibiotics in primary care is associated with Development of antibiotic resistant strains. As part of a quality improvement program carried out in primary care in Uruguay, Argentina, Paraguay and Bolivia, a cluster randomized control trial was performed. The aim of the study was to assess whether the use of continuous evidence-based feedback about management of respiratory tract infections could decrease use of antibiotics in Acute bronchitis, common cold and acute otitis media.

Condition Intervention
Respiratory Infections
Antibiotics
Behavioral: evidence-based online feedback

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Effect of Continuous Evidence-based Feed Back to Increase Appropriate Use of Antibiotics

Resource links provided by NLM:


Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • 20% difference in use of antibiotics in patients with suspected Acute bronchitis [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • 20% difference in the use of antibiotics in suspected acute otitis media [ Time Frame: 3 months ]

Enrollment: 8053
Study Start Date: June 2015
Study Completion Date: August 2015
Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: evidence-based online feedback
During three months GPs will receive weekly feedback about evidence-based management of respiratory tract infections. In order to control that they read the material, there is a questionnaire, they have to fill in every week
Behavioral: evidence-based online feedback
GPs received during three months weekly mails about evidence-based practice and a small questionnaire to reflect about their practice and the new knowledge
No Intervention: control
GPs will register data without receiving online feed-back

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • General practitioners working in primary care
  • Patients with suspected respiratory tract infection

Exclusion Criteria:

  • Patients that have already started an antibiotic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02927743

Locations
Denmark
University of Copenhagen
Copenhagen, Denmark
Sponsors and Collaborators
Gloria Cristina Cordoba
Society of Family Medicin La Paz-Bolivia
University of Itapua, Paraguay
University of the Republic, Uruguay
Society of General and Family practice, Misiones- Argentina
  More Information

Responsible Party: Gloria Cristina Cordoba, MD-MPH, University of Copenhagen
ClinicalTrials.gov Identifier: NCT02927743     History of Changes
Other Study ID Numbers: HAPPY-AUDIT II/cRCT
Study First Received: October 5, 2016
Last Updated: October 6, 2016

Additional relevant MeSH terms:
Respiratory Tract Infections
Infection
Respiratory Tract Diseases
Anti-Bacterial Agents
Anti-Infective Agents

ClinicalTrials.gov processed this record on April 27, 2017